Imiquimod Cream
Product Images NDC 71335-3000

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 71335-3000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

This text appears to be a statistical summary of a study evaluating the effectiveness of Imiquimod Cream. The study involved a total of 109 participants, with a portion completing 16 weeks of treatment and others withdrawing from the study. The results show the number of participants who remained clear of the condition at the end of the treatment period and at the follow-up point. Additionally, it mentions the number of participants for whom the treatment outcome was not clear.*

FDA Label Image

Image 11 (Image 01)

FDA Label Image

Label (Lbl713353000)

This is a description of a medication in the form of a cream containing 12.5mg of Imiquimod per 0.25g single-use packet. The cream also includes various inactive ingredients such as benzyl alcohol, cetyl alcohol, glycerin, and xanthan gum. It is intended for dermatologic use only and should be stored between 4-25°C (39°-77°F). For full dosage recommendations and important information, refer to the package insert by scanning the QR code provided. Note that the package is not child-resistant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.